7:30 am - 5:30 pm
Registration Open
7:30 am - 8:30 am
Preconference Continental Breakfast
Available for registrants of sessions 080 and 090.
8:30 am - 12:00 nn
Optional Half-Day Preconference Workshops (080-090)
Separate registration fee required (see fees).
080
Evidence-Based Practice: Clinical Applications
3.25 CH
Debra Hain, PhD, APRN, ANP-BC, GNP-BC
Mary Haras, PhD, MS, MBA, APN, NP-C, CNN
- Develop a nephrology-based PICOT question, which includes defining a problem, a suggested intervention, evaluating a comparison intervention, and determining the outcome to be accomplished that is being sought over a time frame.
- Recognize sources of evidence and their levels of importance.
- Review examples of clinical applications of evidencebased practice in nephrology.
090
Trends in Pharmacology: Medicare Part D/Medical Marijuana
3.25 CH 2.0 Rx
Wendy St. Peter, PharmD, FCCP, FASN, FNKF
Laura Borgelt, PharmD, FCCP, BCPS, NCMP
- Compare and contrast regulatory issues for use of marijuana in various states.
- Describe the clinical pharmacology, dosage forms, pharmacodynamic impact, therapeutic and adverse effects, drug interactions, and consumer safety issues of marijuana use.
- Describe the development of Medicare Part D, its future, and the potential impact of the dialysis "bundle" on patients and providers.
- Examine trends in medication use in CKD and ESRD patients enrolled in Medicare Part D and overall costs of the program for these patients.
12:00 nn - 1:30 pm
Lunch on your own*
*Registrants will be notified if a corporate-supported symposium is offered during this time slot.
1:30 pm - 2:45 pm
General Session
101
A Retrospective Look at Highlights of Federal Government Policy Toward Treatment of End-Stage Renal Disease
1.25 CH
Richard Rettig, PhD
- Outline the historical path of regulation of care of individuals with kidney disease.
- Relate the impact of regulations on care of individuals with kidney disease.
- Develop a personal picture of the future of care for individuals with kidney disease and the role regulation will play in that scenario.
2:45 pm - 3:00 pm
Stretch Break
3:00 pm - 4:15 pm
General Session
102
Impact of Regulations ~ Renal Pharmacy: Medications and Dosing
1.25 CH.5 Rx
Cheryl Gilmartin, PharmD
- Compare and contrast previous pharmacology medications and orders with changes related to the implementation of renal pharmacies.
- Relate and provide examples of changes that have occurred in prescribing practices.
- Identify an example of how renal pharmacies will impact drug management on a specific process such as bone mineral density.
4:30 pm - 6:30 pm
Exhibits Open / Reception in Exhibit Hall
View the schedule for Friday 
